Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glial Cells01:04

Glial Cells

97.2K
Overview
97.2K
Nervous Tissue: Glial Cells01:31

Nervous Tissue: Glial Cells

12.9K
Glia, or neuroglia, are vital support cells that assist neurons in their functions. The term "glia" originates from the Greek word for "glue," reflecting their role in holding the nervous system together. These cells can be categorized into six types: four in the central nervous system (CNS) and two in the peripheral nervous system (PNS).
The CNS glial cell includes the astrocytes, the oligodendrocytes, the microglia, and the ependymal cells.
Astrocytes are star-shaped glial...
12.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic associations of steroid use in patients with glioblastoma: A population-based study.

Neuro-oncology practice·2026
Same author

Spinal high-grade astrocytoma with piloid features presenting with progressive encephalopathy, hypoglycorrhachia, hydrocephalus, and leptomeningeal dissemination.

Journal of neuropathology and experimental neurology·2026
Same author

Neurosurgeons' perspective on surgical treatment of glioblastoma: Practices, beliefs and willingness to randomize in surgical trials.

Neuro-oncology advances·2026
Same author

Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Microglia up‑regulate thromboxane A2 synthesis genes in response to C6 glioma‑conditioned medium.

Acta neurobiologiae experimentalis·2026
Same author

Educational needs in neuro-oncology: Insights from the European Society for Medical Oncology Central Nervous System Faculty Survey.

Neuro-oncology advances·2026

Related Experiment Video

Updated: Apr 18, 2026

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion
09:23

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion

Published on: October 20, 2016

15.0K

Consensus statement on microglial and macrophage functions in gliomas.

Yuqi Zheng1, Islam Alzoubi2, Manuel B Graeber3

  • 1Ken Parker Brain Tumour Research Laboratories, Brain and Mind Centre, University of Sydney, Camperdown, Australia.

Acta Neuropathologica
|April 16, 2026
PubMed
Summary

Glioma cells manipulate microglia and macrophages (tumor-associated microglia/macrophages or TAMs) to promote tumor growth and resistance. Targeting specific TAMs or using engineered extracellular vesicles offers new therapeutic strategies for glioma.

Keywords:
GliomaImmunotherapyMacrophagesMicrogliaNeurooncology

More Related Videos

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

10.2K
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

16.7K

Related Experiment Videos

Last Updated: Apr 18, 2026

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion
09:23

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion

Published on: October 20, 2016

15.0K
Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

10.2K
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

16.7K

Area of Science:

  • Neuro-oncology
  • Immunology
  • Cell Biology

Background:

  • Microglia and macrophages, collectively known as tumor-associated microglia/macrophages (TAMs), play complex roles in glioma progression and therapeutic resistance.
  • Recent research reveals significant heterogeneity, plasticity, and intricate interactions of TAMs within the glioma microenvironment, challenging traditional classifications.

Purpose of the Study:

  • To synthesize current knowledge on TAMs in glioma, moving beyond simplistic M1/M2 paradigms.
  • To highlight novel therapeutic targets and strategies for glioma treatment based on TAM function and interaction with the tumor microenvironment.

Main Methods:

  • International consensus statement synthesizing recent findings from preclinical and clinical glioma research.
  • Analysis of cellular, spatial, and temporal heterogeneity of TAMs and their interactions with glioma cells, stem cells, and neurons.

Main Results:

  • Glioma cells actively manipulate TAMs to suppress anti-tumor immunity and promote progression.
  • Microglia influence neuron-glioma interactions, fostering tumor advancement.
  • Extracellular vesicles derived from glioblastoma can reprogram microglia to support tumor growth, representing potential therapeutic targets.

Conclusions:

  • A paradigm shift is needed away from simplistic M1/M2 classifications and 'neuroinflammation' terminology.
  • Precision therapies targeting specific TAM subsets or functions, alongside bioengineered extracellular vesicles, show promise for treating gliomas.
  • Modulating the tumor microenvironment to convert immunosuppression into immunostimulation is key to improving patient outcomes in glioblastoma and other gliomas.